Publication: Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes
Issued Date
2021-01-01
Resource Type
ISSN
17583764
17583756
17583756
Other identifier(s)
2-s2.0-85105579149
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
European Cardiology Review. Vol.16, (2021)
Suggested Citation
Jack Wei Chieh Tan, David Sim, Junya Ako, Wael Almahmeed, Mark E. Cooper, Jamshed J. Dalal, Chaicharn Deerochanawong, David Wei Chun Huang, Sofian Johar, Upendra Kaul, Sin Gon Kim, Natalie Koh, Alice Pik Shan Kong, Rungroj Krittayaphong, Bernard Kwok, Bien J. Matawaran, Quang Ngoc Nguyen, Loke Meng Ong, Jin Joo Park, Yongde Peng, David K.L. Quek, Ketut Suastika, Norlela Sukor, Boon Wee Teo, Chee Kiang Teoh, Jian Zhang, Eugenio B. Reyes, Su Yen Goh Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes. European Cardiology Review. Vol.16, (2021). doi:10.15420/ECR.2020.52 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78747
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Consensus recommendations by the asian pacific society of cardiology: Optimising cardiovascular outcomes in patients with type 2 diabetes
Author(s)
Jack Wei Chieh Tan
David Sim
Junya Ako
Wael Almahmeed
Mark E. Cooper
Jamshed J. Dalal
Chaicharn Deerochanawong
David Wei Chun Huang
Sofian Johar
Upendra Kaul
Sin Gon Kim
Natalie Koh
Alice Pik Shan Kong
Rungroj Krittayaphong
Bernard Kwok
Bien J. Matawaran
Quang Ngoc Nguyen
Loke Meng Ong
Jin Joo Park
Yongde Peng
David K.L. Quek
Ketut Suastika
Norlela Sukor
Boon Wee Teo
Chee Kiang Teoh
Jian Zhang
Eugenio B. Reyes
Su Yen Goh
David Sim
Junya Ako
Wael Almahmeed
Mark E. Cooper
Jamshed J. Dalal
Chaicharn Deerochanawong
David Wei Chun Huang
Sofian Johar
Upendra Kaul
Sin Gon Kim
Natalie Koh
Alice Pik Shan Kong
Rungroj Krittayaphong
Bernard Kwok
Bien J. Matawaran
Quang Ngoc Nguyen
Loke Meng Ong
Jin Joo Park
Yongde Peng
David K.L. Quek
Ketut Suastika
Norlela Sukor
Boon Wee Teo
Chee Kiang Teoh
Jian Zhang
Eugenio B. Reyes
Su Yen Goh
Other Contributor(s)
Siriraj Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
Cleveland Clinic Abu Dhabi
Hospital Pulau Pinang
Seoul National University Bundang Hospital
Raja Isteri Pengiran Anak Saleha Hospital
University of the Philippines Manila
University of Santo Tomas, Manila
Hanoi Medical University
National Yang-Ming University Taiwan
Universitas Udayana
Batra Hospital India
Korea University College of Medicine
Hospital Canselor Tuanku Muhriz UKM
NUS Yong Loo Lin School of Medicine
Shanghai Jiao Tong University
Veterans General Hospital-Kaohsiung Taiwan
Institut Jantung Negara Kuala Lumpur
Monash University
Singapore General Hospital
Pantai Holdings Sdn Bhd
Kitasato University
Rajavithi Hospital
National Heart Centre, Singapore
Fooyin University Taiwan
Chinese University of Hong Kong
Sengkang General Hospital
Farrer Park Hospital
Kokilaben Hospital
Chinese Academy of Medical Sciences & Peking Union Medical College
Cleveland Clinic Abu Dhabi
Hospital Pulau Pinang
Seoul National University Bundang Hospital
Raja Isteri Pengiran Anak Saleha Hospital
University of the Philippines Manila
University of Santo Tomas, Manila
Hanoi Medical University
National Yang-Ming University Taiwan
Universitas Udayana
Batra Hospital India
Korea University College of Medicine
Hospital Canselor Tuanku Muhriz UKM
NUS Yong Loo Lin School of Medicine
Shanghai Jiao Tong University
Veterans General Hospital-Kaohsiung Taiwan
Institut Jantung Negara Kuala Lumpur
Monash University
Singapore General Hospital
Pantai Holdings Sdn Bhd
Kitasato University
Rajavithi Hospital
National Heart Centre, Singapore
Fooyin University Taiwan
Chinese University of Hong Kong
Sengkang General Hospital
Farrer Park Hospital
Kokilaben Hospital
Abstract
The Asian Pacific Society of Cardiology convened a consensus statement panel for optimising cardiovascular (CV) outcomes in type 2 diabetes, and reviewed the current literature. Relevant articles were appraised using the Grading of Recommendations, Assessment, Development and Evaluation system, and consensus statements were developed in two meetings and were confirmed through online voting. The consensus statements indicated that lifestyle interventions must be emphasised for patients with prediabetes, and optimal glucose control should be encouraged when possible. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are recommended for patients with chronic kidney disease with adequate renal function, and for patients with heart failure with reduced ejection fraction. In addition to SGLT2i, glucagon-like peptide-1 receptor agonists are recommended for patients at high risk of CV events. A blood pressure target below 140/90 mmHg is generally recommended for patients with type 2 diabetes. Antiplatelet therapy is recommended for secondary prevention in patients with atherosclerotic CV disease.